{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:37:13Z","timestamp":1789875433500,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009594","name":"P\u00e9csi Tudom\u00e1nyegyetem","doi-asserted-by":"publisher","award":["EFOP-3.6.1-16-2016-00004"],"award-info":[{"award-number":["EFOP-3.6.1-16-2016-00004"]}],"id":[{"id":"10.13039\/501100009594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["FK138184"],"award-info":[{"award-number":["FK138184"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["23-04654S"],"award-info":[{"award-number":["23-04654S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","doi-asserted-by":"publisher","award":["BO\/00381\/21"],"award-info":[{"award-number":["BO\/00381\/21"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115548","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T17:52:10Z","timestamp":1695145930000},"page":"115548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Inhibition of xanthine oxidase-catalyzed xanthine and 6-mercaptopurine oxidation by luteolin, naringenin, myricetin, ampelopsin and their conjugated metabolites"],"prefix":"10.1016","volume":"167","author":[{"given":"Orsolya","family":"Bal\u00e1zs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Dombi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs Z.","family":"Zsid\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8013-971X","authenticated-orcid":false,"given":"Csaba","family":"Het\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"Valentov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert G.","family":"Vida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Po\u00f3r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115548_bib1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.nutr.22.111401.144957","article-title":"Dietary flavonoids: bioavailability, metabolic effects, and safety","volume":"22","author":"Ross","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.biopha.2023.115548_bib2","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1080\/10408398.2021.1898333","article-title":"The fate of flavonoids after oral administration: a comprehensive overview of its bioavailability","volume":"62","author":"Naeem","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.biopha.2023.115548_bib3","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.3390\/nu5093367","article-title":"Flavonoid bioavailability and attempts for bioavailability enhancement","volume":"5","author":"Thilakarathna","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2023.115548_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118642","article-title":"Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: an overview","volume":"570","author":"Zhao","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115548_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.phymed.2003.11.002","article-title":"Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans","volume":"12","author":"Wittemer","year":"2005","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2023.115548_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/1987588","article-title":"Paving luteolin therapeutic potentialities and agro-food-pharma applications: emphasis on in vivo pharmacological effects and bioavailability traits","volume":"2021","author":"Taheri","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2023.115548_bib7","doi-asserted-by":"crossref","first-page":"11320","DOI":"10.1021\/acs.jafc.8b03273","article-title":"Absorption and metabolism of luteolin in rats and humans in relation to in vitro anti-inflammatory effects","volume":"66","author":"Hayasaka","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2023.115548_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.lfs.2018.10.066","article-title":"Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update","volume":"215","author":"Joshi","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115548_bib9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1039\/b412577k","article-title":"Screening flavonoid metabolites of naringin and narirutin in urine after human consumption of grapefruit juice by LC-MS and LC-MS\/MS","volume":"129","author":"Zhang","year":"2004","journal-title":"Analyst"},{"key":"10.1016\/j.biopha.2023.115548_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jn\/131.2.235","article-title":"Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice","volume":"131","author":"Erlund","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.biopha.2023.115548_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/dom.13868","article-title":"Safety and pharmacokinetics of naringenin: a randomized, controlled, single\u2010ascending\u2010dose clinical trial","volume":"22","author":"Rebello","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.biopha.2023.115548_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7603\/s40681-014-0016-z","article-title":"Tissue distribution of naringenin conjugated metabolites following repeated dosing of naringin to rats","volume":"4","author":"Lin","year":"2014","journal-title":"BioMedicine"},{"key":"10.1016\/j.biopha.2023.115548_bib13","first-page":"516","article-title":"Quantitative determination of myricetin in rat plasma by ultra performance liquid chromatography tandem mass spectrometry and its absolute bioavailability","volume":"64","author":"Dang","year":"2014","journal-title":"Drug. Res."},{"key":"10.1016\/j.biopha.2023.115548_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/13880209.2016.1266669","article-title":"Determination of dihydromyricetin in rat plasma by LC-MS\/MS and its application to a pharmacokinetic study","volume":"55","author":"Liu","year":"2017","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2023.115548_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jssc.201000382","article-title":"Development and application of high-performance liquid chromatography for the study of ampelopsin pharmacokinetics in rat plasma using cloud-point extraction","volume":"34","author":"Zhou","year":"2011","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.biopha.2023.115548_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jpba.2015.06.030","article-title":"Determination of dihydromyricetin in rat plasma by LC\u2013MS\/MS and its application to a pharmacokinetic study","volume":"114","author":"Tong","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.biopha.2023.115548_bib17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0891-5849(02)00956-5","article-title":"Structure and function of xanthine oxidoreductase: where are we now","volume":"33","author":"Harrison","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2023.115548_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101072","article-title":"The impact of xanthine oxidase (XO) on hemolytic diseases","volume":"21","author":"Schmidt","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2023.115548_bib19","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1097\/MIB.0000000000000923","article-title":"Experts opinion on the practical use of azathioprine and 6-mercaptopurine in inflammatory bowel disease","volume":"22","author":"Mottet","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biopha.2023.115548_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/cbdd.13437","article-title":"Natural compounds with xanthine oxidase inhibitory activity: a review","volume":"93","author":"Mehmood","year":"2019","journal-title":"Chem. Biol. Drug. Des."},{"key":"10.1016\/j.biopha.2023.115548_bib21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1365-2125.1998.00719.x","article-title":"Clinically relevant drug-drug interactions in oncology","volume":"45","author":"McLeod","year":"1998","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.biopha.2023.115548_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/np970237h","article-title":"Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers","volume":"61","author":"Cos","year":"1998","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2023.115548_bib23","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1271\/bbb.63.1787","article-title":"Inhibition of xanthine oxidase by flavonoids","volume":"63","author":"Nagao","year":"1999","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.biopha.2023.115548_bib24","doi-asserted-by":"crossref","first-page":"10781","DOI":"10.1039\/C8RA09926J","article-title":"The interaction of dietary flavonoids with xanthine oxidase in vitro: molecular property-binding affinity relationship aspects","volume":"9","author":"Yuan","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2023.115548_bib25","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3390\/ijms20112681","article-title":"Inhibitory effects of quercetin and its human and microbial metabolites on xanthine oxidase enzyme","volume":"20","author":"Mohos","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115548_bib26","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.3390\/ijms21093256","article-title":"Inhibition of xanthine oxidase-catalyzed xanthine and 6-mercaptopurine oxidation by flavonoid aglycones and some of their conjugates","volume":"21","author":"Mohos","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115548_bib27","doi-asserted-by":"crossref","first-page":"11197","DOI":"10.1021\/acs.jafc.0c03997","article-title":"Sulfated metabolites of luteolin, myricetin, and ampelopsin: chemoenzymatic preparation and biophysical properties","volume":"68","author":"K\u00e1\u0148ov\u00e1","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2023.115548_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114078","article-title":"Interaction of luteolin, naringenin, and their sulfate and glucuronide conjugates with human serum albumin, cytochrome P450 (CYP2C9, CYP2C19, and CYP3A4) enzymes and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters","volume":"157","author":"Kaci","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115548_bib29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/toxins15040250","article-title":"Probing the interactions of 31 mycotoxins with xanthine oxidase: alternariol, alternariol-3-sulfate, and \u03b1-zearalenol are allosteric inhibitors of the enzyme","volume":"15","author":"Bal\u00e1zs","year":"2023","journal-title":"Toxins"},{"key":"10.1016\/j.biopha.2023.115548_bib30","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/biom10030409","article-title":"Testing the pharmacokinetic interactions of 24 colonic flavonoid metabolites with human serum albumin and cytochrome P450 enzymes","volume":"10","author":"Mohos","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2023.115548_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/biom13050755","article-title":"Interaction of fumonisin B1, N-palmitoyl-fumonisin B1, 5-O-palmitoyl-fumonisin B1, and fumonisin B4 mycotoxins with human serum albumin and their toxic impacts on zebrafish embryos","volume":"13","author":"Csenki","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2023.115548_bib32","doi-asserted-by":"crossref","first-page":"8760","DOI":"10.1074\/jbc.M804517200","article-title":"Substrate orientation and catalysis at the molybdenum site in xanthine oxidase","volume":"284","author":"Pauff","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115548_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00894-012-1667-x","article-title":"Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and Re-optimization of parameters","volume":"19","author":"Stewart","year":"2013","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.biopha.2023.115548_bib34","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity \u2013 a rapid access to atomic charges","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"key":"10.1016\/j.biopha.2023.115548_bib35","first-page":"1639","article-title":"Automated docking using a lamarckian genetic algorithm and empirical binding","volume":"19","author":"Morris","year":"1998","journal-title":"Free Energy Funct., J. Comput. Chem."},{"key":"10.1016\/j.biopha.2023.115548_bib36","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1021\/acs.jcim.1c00488","article-title":"Determination of ligand binding modes in hydrated viral ion channels to foster drug design and repositioning","volume":"61","author":"Zsid\u00f3","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.biopha.2023.115548_bib37","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3390\/ijms21020508","article-title":"Synthesis of spin-labelled bergamottin: a potent CYP3A4 inhibitor with antiproliferative activity","volume":"21","author":"Zsid\u00f3","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115548_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-2999(02)02192-1","article-title":"Accurate prediction of xanthine oxidase inhibition based on the structure of flavonoids","volume":"451","author":"Van Hoorn","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115548_bib39","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1016\/j.foodchem.2013.06.092","article-title":"Effect of luteolin on xanthine oxidase: inhibition kinetics and interaction mechanism merging with docking simulation","volume":"141","author":"Yan","year":"2013","journal-title":"Food Chem."},{"key":"10.1016\/j.biopha.2023.115548_bib40","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1039\/D1RA08011C","article-title":"Integrated in silico \u2013 in vitro strategy for the discovery of potential xanthine oxidase inhibitors from egyptian propolis and their synergistic effect with allopurinol and febuxostat","volume":"12","author":"Ghallab","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.biopha.2023.115548_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0006-291X(02)00442-4","article-title":"Molecular modeling of flavonoids that inhibits xanthine oxidase","volume":"294","author":"Lin","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.115548_bib42","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.foodchem.2016.10.136","article-title":"Myricetin inhibits the generation of superoxide anion by reduced form of xanthine oxidase","volume":"221","author":"Zhang","year":"2017","journal-title":"Food Chem."},{"key":"10.1016\/j.biopha.2023.115548_bib43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10616-021-00452-9","article-title":"Comparative effects of quercetin, luteolin, apigenin and their related polyphenols on uric acid production in cultured hepatocytes and suppression of purine bodies-induced hyperuricemia by rutin in mice","volume":"73","author":"Adachi","year":"2021","journal-title":"Cytotechnology"},{"key":"10.1016\/j.biopha.2023.115548_bib44","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.phymed.2018.02.002","article-title":"Luteolin-4'-O-glucoside and its aglycone, two major flavones of Gnaphalium affine D. Don, resist hyperuricemia and acute gouty arthritis activity in animal models","volume":"41","author":"Lin","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2023.115548_bib45","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1248\/bpb.30.1551","article-title":"Hypouricemic action of selected flavonoids in mice: structure-activity relationships","volume":"30","author":"Mo","year":"2007","journal-title":"Biol. Pharm. Bull."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222301346X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222301346X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:38:26Z","timestamp":1776461906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222301346X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":45,"alternative-id":["S075333222301346X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115548","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of xanthine oxidase-catalyzed xanthine and 6-mercaptopurine oxidation by luteolin, naringenin, myricetin, ampelopsin and their conjugated metabolites","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115548"}}